ℹ️ Compiled from public regulatory records · Last regulator revision: January 8, 2026🚩 Report this page
Naja Naja Venom
Active ingredient
Sold as Nyloxin
US FDA
- Drug class
- -
- Availability
- Over-the-counter
- Routes
- Oral, Topical
- Markets covered
- 1
- Products on record
- 3
- FDA reports (12 mo)
- 27
Overview
Naja Naja Venom is an active pharmaceutical ingredient. The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 3 | January 8, 2026 |
USUnited States· FDA
3 products
Uses
Uses:
Temporarily relieves joint pain associated with overuse and pain associated with arthritis.
How to take
Sources & citations
- [1]FDA DailyMed · 0ea98615-f6d3-4f… · revised October 14, 2025 [PDF]
- [2]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.